Viking Therapeutics VKTX
NASDAQ VKTX
$25.83 -0.55 (-2.08%)
At close: Oct 22, 2026 · 4:00 PM EDT

Viking Therapeutics (VKTX) Treasury Shares (2022 - 2023)

Updated

Viking Therapeutics' Treasury Shares was $6.8 million in Q4 2023, unchanged from $6.8 million a year earlier and unchanged from the prior quarter.

Analysis

Viking Therapeutics (VKTX) Treasury Shares (2022 - 2023) Analysis & Trends

From Q1 2022 onward, Viking Therapeutics has reported Treasury Shares for 8 quarters.

  • In earlier years, Treasury Shares was $6.8 million in FY2022.
  • Compared with a year earlier, Treasury Shares was higher in 1 of the last four quarters, with growth averaging 8.2%.
  • Per Business Quant data, VKTX's Treasury Shares in the three quarters before Q4 2023 was $6.8 million (Q3 2023), $6.8 million (Q2 2023) and $6.8 million (Q1 2023).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Treasury Shares (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn -
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn 712.73 Mn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn 77.11 Mn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn 1.11 Bn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 49.00 Mn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn -
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn -
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn 3.94 Bn
10 Viking Therapeutics 2.99 Bn 464.96 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 2.19 Mn
Sep 30, 2023 2.19 Mn
Jun 30, 2023 2.19 Mn
Mar 31, 2023 2.19 Mn
Dec 31, 2022 2.19 Mn
Sep 30, 2022 2.19 Mn
Jun 30, 2022 2.19 Mn
Mar 31, 2022 1.46 Mn
API Access

Viking Therapeutics Treasury Shares API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=treasury-shares&ticker=VKTX&period=max&api_key=YOUR_API_KEY